These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6827165)

  • 41. Inhibition of puerperal lactation with 2-mercaptopropionyl-glycine.
    Akrivis C; Vezyraki P; Kiortsis DN; Fotopoulos A; Evangelou A
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):621-3. PubMed ID: 11214766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma concentrations of prolactin in overtly pseudopregnant Afghan hounds and the effect of metergoline.
    Okkens AC; Dieleman SJ; Kooistra HS; Bevers MM
    J Reprod Fertil Suppl; 1997; 51():295-301. PubMed ID: 9404298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Plasma prolactin concentration and the effect of metergoline in pseudopregnant Afghan hounds].
    Okkens AC; Dieleman SJ; Kooistra HS; Bevers MM
    Tijdschr Diergeneeskd; 2000 Feb; 125(3):81-5. PubMed ID: 10680206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Methergoline in blocking of post-partum lactation].
    Santuari E; Nazzicone Q; Nazzicone P
    Clin Ter; 1980 Oct; 95(2):165-70. PubMed ID: 7471653
    [No Abstract]   [Full Text] [Related]  

  • 45. [The new lactation inhibitors].
    Bagnoli P; Zocchi G
    Minerva Ginecol; 1979 Apr; 31(4):245-50. PubMed ID: 460663
    [No Abstract]   [Full Text] [Related]  

  • 46. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 49. Puerperal lactation inhibition with a novel 8 alpha-aminoergoline (CU 32-085).
    Kvist Poulsen H; Rasmussen P; Riber Petersen M; Møller Pedersen S
    Gynecol Obstet Invest; 1984; 17(3):139-44. PubMed ID: 6706248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of ergocryptine on plasma prolactin, luteinizing hormone, and progesterone in the periparturient sow.
    Whitacre MD; Threlfall WR
    Am J Vet Res; 1981 Sep; 42(9):1538-41. PubMed ID: 6895686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The suppression of puerperal lactation with bromocryptine.
    Willmott MP; Colhoun EM; Bolton AE
    Acta Obstet Gynecol Scand; 1977; 56(2):145-9. PubMed ID: 324230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of lactation with lisuride.
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Methergoline in the prevention and interruption of puerperal lactation: a multicenter clinico-biological study].
    Bareggi SR; Pellicciotta G; Pontiroli AE; Pollini C; Praga C
    Farmaco Prat; 1982 Mar; 37(3):98-108. PubMed ID: 7040101
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of metergoline on serum prolactin stimulated by TRH.
    Iannotta F; Gadaleta G; Pollini C; Vettaro MP
    J Endocrinol Invest; 1980; 3(3):301-3. PubMed ID: 6776182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Ferrari C; Caldara R; Rampini P; Telloli P; Romussi M; Bertazzoni A; Polloni G; Mattei A; Crosignani PG
    Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metergoline abolishes the prolactin response to buspirone.
    Gregory CA; Anderson IM; Cowen PJ
    Psychopharmacology (Berl); 1990; 100(2):283-4. PubMed ID: 2305017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
    Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
    Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.